Current Neuropharmacology
Title:Meet Our Editorial Board Member
Volume: 19 Issue: 7
Author(s): Peter Illes
Affiliation:
Export Options
About this article
Cite this article as:
Illes Peter , Meet Our Editorial Board Member, Current Neuropharmacology 2021; 19 (7) . https://dx.doi.org/10.2174/1570159X1907210527103504
DOI https://dx.doi.org/10.2174/1570159X1907210527103504 |
Print ISSN 1570-159X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6190 |
15
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Magnetite Nanostructures with Applications in Cancer Therapy
Current Proteomics Jurisprudence Study of Muslim Rules and Effects of Ovarian Transplants in Women with Infertility; A Review
Current Women`s Health Reviews Chelating Agents for the Sequestration of Mercury(II) and Monomethyl Mercury(II)
Current Medicinal Chemistry Genetics and Pathophysiology of Neurodegeneration with Brain Iron Accumulation (NBIA)
Current Neuropharmacology Different Levels of Activity in the Left Intraparietal Sulcus Triggered by Lasting and Unlasting Cues in the Posner Task
Neuroscience and Biomedical Engineering (Discontinued) Non-Analgesic Effects of Opioids: Interactions Between Opioids and Other Drugs
Current Pharmaceutical Design EDITORIAL: Neuroprotection Mechanisms and their Potential Applications
Current Neuropharmacology Cell and Gene-Based Therapies for the Lysosomal Storage Diseases
Current Gene Therapy Optimization of Antidepressant Use with Pharmacogenetic Strategies
Current Genomics The Neurobiological Mechanisms and Treatments of REM Sleep Disturbances in Depression
Current Neuropharmacology NMDA Pathology and Treatment of Schizophrenia
Current Pharmaceutical Design Neuropsychiatric Disturbances in Alzheimer’s Disease: What Have We Learned from Neuropathological Studies?
Current Alzheimer Research P2X7 Receptor-Associated Programmed Cell Death in the Pathophysiology of Hemorrhagic Stroke
Current Neuropharmacology Chemical and Physical Properties and Potential Mechanisms: Melatonin as a Broad Spectrum Antioxidant and Free Radical Scavenger
Current Topics in Medicinal Chemistry Recent Advances in the Synthesis of Naratriptan: An Anti-Migraine Drug
Mini-Reviews in Organic Chemistry Interferon gama induced Tryptophan Degradation Neuropsychiatric and Immunological Consequences
Current Drug Metabolism Agonist-Trafficking and Hallucinogens
Current Medicinal Chemistry Inflammatory Process as a Determinant Factor for the Degeneration of Substantia Nigra Dopaminergic Neurons: Possible Relevance to the Etiology of Parkinsons Disease
Current Medicinal Chemistry - Central Nervous System Agents Sudden Death and Ventricular Preexcitation: Is it Necessary to Treat the Asymptomatic Patients?
Current Pharmaceutical Design Patented In Vitro Blood-Brain Barrier Models in CNS Drug Discovery
Recent Patents on CNS Drug Discovery (Discontinued)